Avanos Medical (AVNS) Receivables (2013 - 2026)

Avanos Medical has disclosed Receivables across 14 years of filings, most recently posting $106.3 million for Q1 2026.

• Receivables for Q1 2026 came in at $106.3 million, down 3.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $106.3 million (down 3.28% YoY), and the FY2025 annual result was $108.0 million, down 19.16% from the prior year.
• Receivables came in at $106.3 million for Q1 2026 at Avanos Medical, down from $108.0 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $167.9 million in Q4 2022 to a low of $106.3 million in Q1 2026.
• The 5-year median for Receivables is $133.6 million (2024), against an average of $133.8 million.
• Across the five-year window, Receivables surged 47.58% in 2022 and declined 19.16% in 2025, its largest moves.
• Avanos Medical's Receivables stood at $167.9 million in 2022, then slipped by 14.95% to $142.8 million in 2023, then retreated by 6.44% to $133.6 million in 2024, then declined by 19.16% to $108.0 million in 2025, then dropped by 1.57% to $106.3 million in 2026.
• The last three Receivables figures came in at $106.3 million (Q1 2026), $108.0 million (Q4 2025), and $111.5 million (Q3 2025), per Business Quant data.